Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)


  • Multiple therapeutic options may prevent apoptosis in the treatment of NASH (Table 17)
  • In one study of 247 nondiabetic adults, 43% of those receiving vitamin E experienced improvements in NASH vs placebo (19%; P = .001)[Sanyal 2010]
  • Results of large-scale, well-controlled trials are needed before they can be recommended for HIV-infected patients in the treatment of NASH

Action required